MedPath

Counteracting Learned Non-use Through Augmented Visuomotor Feedback in Virtual Reality (RGS)

Not Applicable
Completed
Conditions
Hemiparesis
Interventions
Behavioral: Reinforcement-Induced Movement Therapy (RIMT)
Behavioral: VR-based motor rehabilitation in RGS without augmented feedback
Registration Number
NCT02657070
Lead Sponsor
Universitat Pompeu Fabra
Brief Summary

The purpose of this study is to determine if Reinforcement-Induced Movement Therapy (RIMT), a novel rehabilitation method that augments visuomotor feedback of movements of the patient in virtual reality, is effective in treating hemiparesis resp. learned non-use.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
23
Inclusion Criteria
  • Mild-to-moderate upper-limbs hemiparesis (Proximal Medical Research Council Scale > 2) due to ischemic or hemorrhagic stroke
  • Spasticity in the affected limb (Modified Ashworth Scale <3)
  • First-ever ischemic or hemorrhagic stroke (>4 weeks post-stroke)
  • Sufficient cognitive capacity for following the instruction of the intervention (Mini-Mental State Evaluation >24)
Exclusion Criteria
  • Cognitive impairment that impede the correct execution or understanding of the intervention
  • Severe impairments in vision or visual perception abilities (such as vision loss or spatial neglect), in spasticity, in communication abilities (such as aphasia or apraxia), severe pain as well as other neuromuscular or orthopedic changes that impede the correct execution of the intervention training
  • Mental dysfunctioning during the acute or subacute phase after the stroke.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Experimental GroupReinforcement-Induced Movement Therapy (RIMT)Virtual reality based therapy with augmented visuomotor feedback.
Control GroupVR-based motor rehabilitation in RGS without augmented feedbackVirtual reality based therapy without augmentation.
Primary Outcome Measures
NameTimeMethod
The upper extremity Fugl-Meyer Assessmentat baseline, at 6-weeks (after intervention), and at 12-weeks follow-up

change from baseline in motor function

Secondary Outcome Measures
NameTimeMethod
Chedoke Arm Hand Inventoryat baseline, at 6-weeks (after intervention), and at 12-weeks follow-up

change from baseline in functional recovery

Barthel Indexat baseline, at 6-weeks (after intervention), and at 12-weeks follow-up

change from baseline in activities of daily living

Hamilton Scaleat baseline, at 6-weeks (after intervention), and at 12-weeks follow-up

change from baseline in measurement of depression

© Copyright 2025. All Rights Reserved by MedPath